MAK Capital Fund LP Increases Stake in ClearPoint Neuro, Inc. to 6.3%

On May 15, 2026, MAK Capital Fund LP, MAK Capital One L.L.C., and Michael A. Kaufman filed a Schedule 13G/A with the SEC, reporting a significant increase in their position in ClearPoint Neuro, Inc. (CLPT). The reporting persons disclosed beneficial ownership of 1,901,489 shares of common stock, representing 6.3% of the class. This filing marks an increase from a previous ownership level of 0.0%. The shares are held with shared voting and dispositive power among the reporting entities. Specifically, MAK Fund is a Bermuda limited partnership, MAK Capital One is a Delaware LLC, and Mr. Kaufman is a U.S. citizen. The calculation of the ownership percentage is based on 29,989,563 shares of common stock outstanding as of May 7, 2026. The reporting persons certified that the securities were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer.